Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide IV effects on EEG/EKG in focal epilepsy
NCT01724918Phase 2Terminated
- Start
- May 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lacosamide in focal epilepsy. Started May 2013; status: terminated.
02
Drugs
lacosamide
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT01724918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724918.